Recursion is at a strategic inflection point. With a growing clinical pipeline, expanding global partnerships, and one of the most powerful AI-native end-to-end drug discovery platforms, we are seeking a strategist who can translate intelligence into decisive action. At Recursion, our mission is to industrialize and transform the development of medicines by integrating data-driven insights and advanced analytics throughout the entire development lifecycle.
As an Executive Director in Corporate Strategy & Intelligence, you will play a pivotal role in defining Recursion’s competitive and commercial position and turn that understanding into a strategy that shapes pipeline prioritization, partnership decisions, and long-range growth. You will leverage competitive & commercial insights to be a principal architect of Recursion’s strategic choices, sharpening our BD focus and maximizing the potential for both scientific and commercial impact. Ideal candidates are equally comfortable building rigorous commercial models as they are presenting bold strategic recommendations to leadership, all with the goal of driving enterprise decision-making as we advance transformative medicines for patients.
In this role, you will:
Lead commercial assessment, strategic fit analyses, and the design of competitive moats for pipeline assets from early validation through late-stage development. Integrate epidemiology, patient segmentation, competitive positioning, pricing & market access dynamics, and revenue forecasts to inform go/no-go, prioritization, and partnering decisions.
Own the end-to-end competitive intelligence function for specific Recursion initiatives and BD opportunities: leverage agentic approaches, as well as advanced analytics & modeling to define the strategic framework, build the intelligence infrastructure, and deliver timely, decision-grade insights on competitors, therapeutic area dynamics, evolving platform technologies, and the broader drug discovery ecosystem.
Grow and refine a real-time intelligence system that synthesizes complex signals from clinical data, regulatory filings, investor disclosures, scientific publications, partner pipelines, and industry events into a coherent, real-time-updated strategic picture. Strive to preempt market disruptions and identify white space opportunities.
Collaborate with functional line leaders and the C-suite to inform corporate strategy development and long-range planning, translating competitive and commercial intelligence into actionable strategic choices and high impact narratives on portfolio prioritization, platform positioning, partnership strategy, and growth vectors.
Propagate the Recursion mindset of radically changing lives by constantly seeking transformative improvements in how we advance innovative concepts for clinical benefit, all while ensuring Recursion’s strategy is grounded in competitive reality and built to move with urgency.
The Team You’ll Join
As Executive Director, Corporate Strategy & Intelligence, you will work across the Recursion Portfolio, partnering with colleagues in Discovery, Platform, External Partnerships, ClinTech and Clinical Development. The Portfolio Team is an empowered, execution-minded group of cross-functional professionals responsible for translating and industrializing Recursion’s innovative science to patients. We value rigorous analytical thinking, intellectual honesty, a bilingual tech/science mindset and a shared mission to revolutionize how drugs are discovered. We break down traditional silos across the organization, leveraging AI-powered platforms to connect the dots between the discovery portfolio, clinical development, and commercial reality.
The Experience You’ll Need
Advanced degree in a scientific, quantitative, business, or related field required; MBA, PhD, MD, or equivalent strongly preferred
10+ years of experience in competitive intelligence, pipeline differentiation strategy, forecasting and demand estimation, quantitative and qualitative market research, corporate strategy & business development in the pharma, biotech and/or life sciences consulting sector
Deep command of the drug development landscape, including therapeutic area dynamics, clinical-stage competitive assessments, regulatory strategy, and market access considerations
Proven track record building and delivering commercial assessments and strategic analyses that have directly influenced high-stakes decisions: pipeline prioritization, partnership strategy, go/no-go investments
Experience with AI-enabled drug discovery or platform biotechs is an advantage; as is an ability to translate complex platform capabilities into compelling commercial and competitive narratives
Experience partnering on or advising business development transactions (licensing, co-development, M&A) in a competitive intelligence or strategic context
Strong financial and analytical acumen: able to build, own, and critically challenge commercial models, scenario analyses, and valuation frameworks
Exceptional communication and executive presence—able to synthesize complexity into clear, actionable recommendations and present with confidence and conviction to internal and external stakeholders
Working Location & Compensation:
This is an office-based, hybrid position in our New York City office. Employees are expected to work in the office at least 50% of the time.
At Recursion, we believe that every employee should be compensated fairly. Based on the skills, experience, and qualifications needed for this role, the estimated annual base salary range is: $287,980-$346,060. In addition to base salary, this role is eligible for an annual bonus, equity compensation, and a comprehensive benefits package.
#LI-EP1
The Values We Hope You Share:
We act boldly with integrity. We are unconstrained in our thinking, take calculated risks, and push boundaries, but never at the expense of ethics, science, or trust.
We care deeply and engage directly. Caring means holding a deep sense of responsibility and respect - showing up, speaking honestly, and taking action.
We learn actively and adapt rapidly. Progress comes from doing. We experiment, test, and refine, embracing iteration over perfection.
We move with urgency because patients are waiting. Speed isn’t about rushing but about moving the needle every day.
We take ownership and accountability. Through ownership and accountability, we enable trust and autonomy—leaders take accountability for decisive action, and teams own outcomes together.
We are One Recursion. True cross-functional collaboration is about trust, clarity, humility, and impact. Through sharing, we can be greater than the sum of our individual capabilities.
Our values underpin the employee experience at Recursion. They are the character and personality of the company demonstrated through how we communicate, support one another, spend our time, make decisions, and celebrate collectively.
More About Recursion
Recursion (NASDAQ: RXRX) is a clinical-stage TechBio company decoding biology to radically improve lives. Recursion is advancing a portfolio of differentiated investigational medicines across its wholly owned and partnered pipeline in oncology, rare disease, neuroscience, immunology, and other therapeutic areas with significant unmet need. Enabling its mission is the Recursion OS, an AI-native, end-to-end drug discovery and development platform integrating biology, chemistry, and clinical development into a unified intelligence system. Powered by proprietary multimodal data, purpose-built AI models, and bilingual teams fluent in both science and AI, the Recursion OS is designed to translate complex science into medicines that matter — faster, better, and at scale — for patients who are waiting.
Recursion’s platform infrastructure is anchored in Salt Lake City, Utah and Milton Park, Oxfordshire, where its automated biology and chemistry laboratories generate proprietary data at industrial scale. Recursion also maintains offices in New York, Montréal, and London, three global hubs for talent and leadership at the intersection of AI and scientific innovation. Learn more at www.recursion.com, or connect on X and LinkedIn.
Recursion is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, veteran status, or any other characteristic protected under applicable federal, state, local, or provincial human rights legislation.
Accommodations are available on request for candidates taking part in all aspects of the selection process.
Recruitment & Staffing Agencies: Recursion Pharmaceuticals and its affiliate companies do not accept resumes from any source other than candidates. The submission of resumes by recruitment or staffing agencies to Recursion or its employees is strictly prohibited unless contacted directly by Recursion’s internal Talent Acquisition team. Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of Recursion, and Recursion will not owe any referral or other fees. Our team will communicate directly with candidates who are not represented by an agent or intermediary unless otherwise agreed to prior to interviewing for the job.
Skills called out
Go
Ghost-job notes
We re-verify every URL daily. This listing currently scores 100/100 based on aggregate cohort reply rate, age (1d), and repost frequency.
Pulled directly from Recursion Pharmaceuticals’s Greenhouse hiring system — not a third-party aggregator. The apply link goes straight to the employer, and this req drops out of our feed when it closes. Last synced 2 hours ago.
Match breakdown
See how well this role fits you
Sign in to see your match breakdown — a transparent, per-dimension score across skills, seniority, industry, freshness, location, and visa fit.